Opinion | Fears About New Rules on Masks Outdoors

More from our inbox:

To the Editor:

Re “C.D.C. Relaxes Its Rules on Mask Use Outdoors for the Fully Inoculated” (front page, April 28):

With the new guidelines, the C.D.C. provides some light at the end of the tunnel — at least for those who chose to be vaccinated.

Scientifically, we recognize that the risk of viral transmission outside is low. However, socially, who will govern the maskless to ensure that they are indeed vaccinated? Mentally, are we going to feel safe interacting without masks? What about the children under 16 without available vaccination?

With the new guidelines open for interpretation, only time will tell the shortcomings to this huge leap toward the pre-Covid era.

Sonia Hur
Long Island City, Queens
The writer is a student at New York Medical College.

To the Editor:

These new guidelines are making me cringe! I am a kidney transplant patient and therefore have a weakened immune system. I was fully vaccinated in February. This month I was tested to see if I produced antibodies from the Covid vaccine. I did not.

I directed three of my friends who are also immunocompromised to get tested. They also did not show antibodies. According to my doctors, I have to be masked and distanced even with my family members who are vaccinated. There are millions of people who are immunocompromised and do not know that the vaccine might not be effective for them.

It is irresponsible for the C.D.C. to claim that vaccinated people can go out unmasked! Speaking as someone who has a weakened immune system (and there are millions of us), I do not want to be a guinea pig for the medical establishment before they know all the facts.

Yes, get vaccinated! But also, if you’re immunocompromised, get tested so you know if you are safe.

Diana Laufer
Los Angeles

To the Editor:

I find that wearing a mask outdoors during the worst of the spring tree-pollen season helps keep me from sneezing my head off. I’m happy to ditch the mask, of course, but — kerchoo!

Robert Kinerk
Cambridge, Mass.

How the U.S. Benefits by Sending Vaccines Abroad

To the Editor:

Re “U.S. to Send 60 Million Vaccine Doses Abroad” (front page, April 27):

It is not only a humanitarian imperative for the United States to send vaccines to India, but also a protective measure for the U.S. supply of generic medication.

India, “the world’s pharmacy,” supplies approximately 40 percent of generic drugs to the United States. Disruptions in the supply chain for widely used generic medications while India battles a devastating surge of Covid-19 can lead to a shortage or increased prices for American patients. India has already restricted export of remdesivir, reserving supply for its own use.

Many states find themselves with a vaccine surplus even as all Americans 16 and older are eligible for vaccination. Sharing vaccine doses is a vital step in battling this pandemic as well as an opportunity to mitigate the potential impact of supply issues on much-needed generic medications for U.S. patients.

Kelly Burns
Stonington, Conn.

Source: Read Full Article